Novo Nordisk: Vi har indregnet at Roche får et super produkt

Novo Nordisk har siden efteråret 2015 ladet investorer og aktieanalytikere forstå, at selskabets blødermiddel Novoseven risikerer skarp konkurrence fra schweiziske Roche, der “Vi har s …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: